Related Experiment Video
Updated: Jun 24, 2026
09:08
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Prognostic value of CCN3 in osteosarcoma.
Bernard Perbal1, Monia Zuntini, Diana Zambelli
1Laboratorio di Ricerca Oncologica and Laboratorio di Rigenerazione Tissutale Ossea, Istituti Ortopedici Rizzoli, Bologna, Italy.
Summary
Osteosarcoma prognosis may be improved by measuring CCN3 gene expression. High CCN3 levels indicate a worse outcome, unlike CCN1 and CCN2, which lack prognostic value in this bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma, a prevalent bone tumor, requires better prognostic markers for personalized treatment.
- CCN family genes (CCN1, CCN2, CCN3) play roles in cellular processes, but their prognostic significance in osteosarcoma is unclear.
Purpose of the Study:
- To evaluate the prognostic value of CCN1, CCN2, and CCN3 gene expression in osteosarcoma.
- To investigate the association of these genes with osteoblastic differentiation and drug response.
Main Methods:
- Quantitative PCR was used to measure CCN1, CCN2, and CCN3 expression in 45 osteosarcoma samples.
- Kaplan-Meier analysis estimated cancer-specific survival.
- Spearman correlation and Fisher's exact tests assessed associations with differentiation and drug response genes.
Main Results:
- CCN1 and CCN2 expression correlated with osteoblastic differentiation markers.
- CCN3 was highly expressed in osteosarcoma, unlike normal cells, and did not correlate with differentiation markers.
- High CCN3 expression significantly predicted worse prognosis, partly due to association with multidrug resistance genes.
Conclusions:
- CCN1 and CCN2 expression lack prognostic relevance in osteosarcoma.
- CCN3 expression at diagnosis may serve as a valuable tool for early identification of patients with different prognoses.
- Distinctive CCN gene expression patterns highlight differences in normal versus osteosarcoma cell differentiation.
